SS Innovations Expands Telesurgery Footprint to Indonesia and Philippines
Event summary
- SS Innovations' SSi Mantra surgical robotic system approved for telesurgeries in Indonesia and the Philippines.
- Over 150 cumulative telesurgeries performed using the SSi Mantra, primarily in India.
- 18 inter-hospital telesurgeries conducted between two Indian cities on February 14, 2026.
- Global Multi-Specialty Robotic Surgery Conference 2026 to feature over 20 live telesurgeries using the SSi Mantra.
The big picture
SS Innovations is positioning itself as a leader in affordable and accessible robotic surgery, leveraging telesurgery to overcome geographical barriers. The approval in Indonesia and the Philippines marks a strategic expansion into Southeast Asia, a region with significant healthcare infrastructure gaps. The company's focus on modular, multi-arm systems and comprehensive surgical instruments underscores its commitment to driving equitable access to quality healthcare.
What we're watching
- Market Expansion
- The pace at which SS Innovations can scale its telesurgery capabilities in new markets like Indonesia and the Philippines.
- Technological Adoption
- How the SSi Mantra's advanced telesurgery capabilities will influence the adoption of robotic surgery in emerging markets.
- Regulatory Dynamics
- Whether SS Innovations can maintain regulatory approvals and expand into additional geographies.